Cognetivity Neurosciences Ltd.
CGNSF
$0.0023
-$0.0077-77.00%
| 10/31/2023 | 07/31/2023 | 04/30/2023 | 01/31/2023 | 10/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -3.40% | 6.77% | 18.22% | -41.00% | -9.21% |
| Total Depreciation and Amortization | -10.53% | 11.76% | 41.67% | -26.53% | -7.55% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4.66% | -5.43% | 13.15% | 3,209.57% | -125.81% |
| Change in Net Operating Assets | 943.74% | 89.91% | -122.48% | -123.91% | 42.06% |
| Cash from Operations | 102.49% | 55.49% | 9.55% | -637.06% | 36.02% |
| Capital Expenditure | -- | 200.00% | -700.00% | -111.11% | 123.68% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -191.49% | -80.77% | -181.25% | 131.68% | 22.31% |
| Cash from Investing | -251.28% | -14.71% | -209.68% | 133.70% | 45.24% |
| Total Debt Issued | -- | -- | -- | -6,747.83% | -98.47% |
| Total Debt Repaid | -2.65% | -- | -- | 5,300.00% | -33.33% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00% | -- | -- | -104.73% | 2,653.62% |
| Foreign Exchange rate Adjustments | 97.50% | -190.91% | 266.67% | 340.00% | -145.45% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 98.09% | 54.00% | 19.26% | -145.66% | 1,978.94% |
